The cost-effectiveness of graftskin vs. standard care for diabetic foot ulcers

被引：0
|
作者：
Beusterien, K
Plante, K
Nordin, J
Kim, J
Arcona, S
Steinberg, J
Chaikof, E
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A496 / A496
页数：1
相关论文
共 50 条
  • [11] Economics of a new treatment for diabetic foot ulcers:: The cost-effectiveness of becaplermin in Sweden
    Willis, M
    Persson, U
    Ödegaard, K
    DIABETOLOGIA, 1999, 42 : A309 - A309
  • [12] Response to: Remote Diabetic Foot Temperature Monitoring for Early Detection of Diabetic Foot Ulcers: A Cost-Effectiveness Analysis
    van Netten, Jaap J.
    Dijkgraaf, Marcel G. W.
    Bus, Sicco A.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 49 - 50
  • [13] Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
    Dorian, Paul
    Kongnakorn, Thitima
    Phatak, Hemant
    Rublee, Dale A.
    Kuznik, Andreas
    Lanitis, Tereza
    Liu, Larry Z.
    Iloeje, Uchenna
    Hernandez, Luis
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1897 - 1906
  • [14] COST-EFFECTIVENESS ANALYSIS OF NON-INVASIVE SCREENING IN PATIENTS WITH DIABETIC FOOT ULCERS
    Gu, B.
    Padula, W.
    Armstrong, D. G.
    VALUE IN HEALTH, 2022, 25 (07) : S417 - S417
  • [15] PLATELET-RICH PLASMA IN DIABETIC FOOT ULCERS: COST-EFFECTIVENESS ANALYSIS FOR SPAIN
    Linertova, R.
    Del Pino Sedeno, T.
    Garcia-Perez, L.
    Aragon-Sanchez, J.
    Kaiser-Girardot, S.
    Trujillo-Martin, Md
    Serrano-Aguilar, P.
    VALUE IN HEALTH, 2018, 21 : S130 - S130
  • [16] Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers
    Chuck, Anderson W.
    Hailey, David
    Jacobs, Philip
    Perry, Douglas C.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (02) : 178 - 183
  • [17] The cost effectiveness of Apligraf® treatment of diabetic foot ulcers
    W. Ken Redekop
    Joseph McDonnell
    Paul Verboom
    Kornelia Lovas
    Zoltan Kalo
    PharmacoEconomics, 2003, 21 : 1171 - 1183
  • [18] The cost effectiveness of Apligraf® treatment of diabetic foot ulcers
    Redekop, WK
    McDonnell, J
    Verboom, P
    Lovas, K
    Kalo, Z
    PHARMACOECONOMICS, 2003, 21 (16) : 1171 - 1183
  • [19] Graftskin bilayered living skin construct in the treatment of diabetic foot ulcers
    Sabolinski, M
    Toole, T
    Giovino, K
    Veves, A
    DIABETOLOGIA, 2000, 43 : A16 - A16
  • [20] Cost-Effectiveness Analysis for Managing Diabetic Foot Ulcer (DFU) in USA: Platelet-Rich Plasma (PRP) vs Standard of Care (SoC)
    Russo, Salvatore
    Landi, Stefano
    Simoni, Stefania
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2025, 17 : 157 - 169
12345